Market Research Report

Bevacizumab Monoclonal Antibody Biosimilar Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-3280
  • CAT ID : 7
  • Pages : 113
  • Date : Jun 2023
 

The global Bevacizumab Monoclonal Antibody Biosimilar market was valued at US$ 1379.8 million in 2022 and is projected to reach US$ 484.9 million by 2029, at a CAGR of -13.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
400mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bevacizumab Monoclonal Antibody Biosimilar include Celltrion, Amneal, Pfizer and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.
This report aims to provide a comprehensive presentation of the global market for Bevacizumab Monoclonal Antibody Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bevacizumab Monoclonal Antibody Biosimilar. This report contains market size and forecasts of Bevacizumab Monoclonal Antibody Biosimilar in global, including the following market information:
Global Bevacizumab Monoclonal Antibody Biosimilar Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bevacizumab Monoclonal Antibody Biosimilar Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Bevacizumab Monoclonal Antibody Biosimilar companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bevacizumab Monoclonal Antibody Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bevacizumab Monoclonal Antibody Biosimilar Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar Market Segment Percentages, by Type, 2022 (%)
400mg
100mg
Global Bevacizumab Monoclonal Antibody Biosimilar Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar Market Segment Percentages, by Application, 2022 (%)
Cancer
Wet Age-related Macular Degeneration
Other
Global Bevacizumab Monoclonal Antibody Biosimilar Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bevacizumab Monoclonal Antibody Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bevacizumab Monoclonal Antibody Biosimilar revenues share in global market, 2022 (%)
Key companies Bevacizumab Monoclonal Antibody Biosimilar sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Bevacizumab Monoclonal Antibody Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celltrion
Amneal
Pfizer
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bevacizumab Monoclonal Antibody Biosimilar, market overview.
Chapter 2: Global Bevacizumab Monoclonal Antibody Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Bevacizumab Monoclonal Antibody Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bevacizumab Monoclonal Antibody Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bevacizumab Monoclonal Antibody Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Bevacizumab Monoclonal Antibody Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bevacizumab Monoclonal Antibody Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bevacizumab Monoclonal Antibody Biosimilar Overall Market Size
2.1 Global Bevacizumab Monoclonal Antibody Biosimilar Market Size: 2022 VS 2029
2.2 Global Bevacizumab Monoclonal Antibody Biosimilar Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Bevacizumab Monoclonal Antibody Biosimilar Sales: 2018-2029
3 Company Landscape
3.1 Top Bevacizumab Monoclonal Antibody Biosimilar Players in Global Market
3.2 Top Global Bevacizumab Monoclonal Antibody Biosimilar Companies Ranked by Revenue
3.3 Global Bevacizumab Monoclonal Antibody Biosimilar Revenue by Companies
3.4 Global Bevacizumab Monoclonal Antibody Biosimilar Sales by Companies
3.5 Global Bevacizumab Monoclonal Antibody Biosimilar Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Bevacizumab Monoclonal Antibody Biosimilar Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bevacizumab Monoclonal Antibody Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Bevacizumab Monoclonal Antibody Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Bevacizumab Monoclonal Antibody Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Market Size Markets, 2022 & 2029
4.1.2 400mg
4.1.3 100mg
4.2 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2018-2023
4.2.2 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2024-2029
4.2.3 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue Market Share, 2018-2029
4.3 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Sales & Forecasts
4.3.1 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Sales, 2018-2023
4.3.2 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Sales, 2024-2029
4.3.3 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Sales Market Share, 2018-2029
4.4 By Type - Global Bevacizumab Monoclonal Antibody Biosimilar Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Wet Age-related Macular Degeneration
5.1.4 Other
5.2 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2018-2023
5.2.2 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2024-2029
5.2.3 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue Market Share, 2018-2029
5.3 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Sales & Forecasts
5.3.1 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Sales, 2018-2023
5.3.2 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Sales, 2024-2029
5.3.3 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Sales Market Share, 2018-2029
5.4 By Application - Global Bevacizumab Monoclonal Antibody Biosimilar Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2022 & 2029
6.2 By Region - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2018-2023
6.2.2 By Region - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2024-2029
6.2.3 By Region - Global Bevacizumab Monoclonal Antibody Biosimilar Revenue Market Share, 2018-2029
6.3 By Region - Global Bevacizumab Monoclonal Antibody Biosimilar Sales & Forecasts
6.3.1 By Region - Global Bevacizumab Monoclonal Antibody Biosimilar Sales, 2018-2023
6.3.2 By Region - Global Bevacizumab Monoclonal Antibody Biosimilar Sales, 2024-2029
6.3.3 By Region - Global Bevacizumab Monoclonal Antibody Biosimilar Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2018-2029
6.4.2 By Country - North America Bevacizumab Monoclonal Antibody Biosimilar Sales, 2018-2029
6.4.3 US Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.4.4 Canada Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.4.5 Mexico Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2018-2029
6.5.2 By Country - Europe Bevacizumab Monoclonal Antibody Biosimilar Sales, 2018-2029
6.5.3 Germany Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.5.4 France Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.5.5 U.K. Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.5.6 Italy Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.5.7 Russia Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.5.8 Nordic Countries Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.5.9 Benelux Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2018-2029
6.6.2 By Region - Asia Bevacizumab Monoclonal Antibody Biosimilar Sales, 2018-2029
6.6.3 China Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.6.4 Japan Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.6.5 South Korea Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.6.6 Southeast Asia Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.6.7 India Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2018-2029
6.7.2 By Country - South America Bevacizumab Monoclonal Antibody Biosimilar Sales, 2018-2029
6.7.3 Brazil Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.7.4 Argentina Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bevacizumab Monoclonal Antibody Biosimilar Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Bevacizumab Monoclonal Antibody Biosimilar Sales, 2018-2029
6.8.3 Turkey Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.8.4 Israel Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.8.5 Saudi Arabia Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
6.8.6 UAE Bevacizumab Monoclonal Antibody Biosimilar Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Celltrion
7.1.1 Celltrion Company Summary
7.1.2 Celltrion Business Overview
7.1.3 Celltrion Bevacizumab Monoclonal Antibody Biosimilar Major Product Offerings
7.1.4 Celltrion Bevacizumab Monoclonal Antibody Biosimilar Sales and Revenue in Global (2018-2023)
7.1.5 Celltrion Key News & Latest Developments
7.2 Amneal
7.2.1 Amneal Company Summary
7.2.2 Amneal Business Overview
7.2.3 Amneal Bevacizumab Monoclonal Antibody Biosimilar Major Product Offerings
7.2.4 Amneal Bevacizumab Monoclonal Antibody Biosimilar Sales and Revenue in Global (2018-2023)
7.2.5 Amneal Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Bevacizumab Monoclonal Antibody Biosimilar Major Product Offerings
7.3.4 Pfizer Bevacizumab Monoclonal Antibody Biosimilar Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Bevacizumab Monoclonal Antibody Biosimilar Major Product Offerings
7.4.4 Amgen Bevacizumab Monoclonal Antibody Biosimilar Sales and Revenue in Global (2018-2023)
7.4.5 Amgen Key News & Latest Developments
8 Global Bevacizumab Monoclonal Antibody Biosimilar Production Capacity, Analysis
8.1 Global Bevacizumab Monoclonal Antibody Biosimilar Production Capacity, 2018-2029
8.2 Bevacizumab Monoclonal Antibody Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Bevacizumab Monoclonal Antibody Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bevacizumab Monoclonal Antibody Biosimilar Supply Chain Analysis
10.1 Bevacizumab Monoclonal Antibody Biosimilar Industry Value Chain
10.2 Bevacizumab Monoclonal Antibody Biosimilar Upstream Market
10.3 Bevacizumab Monoclonal Antibody Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bevacizumab Monoclonal Antibody Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250

Corporate User : $4225

Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe